[{"arm_notes": "", "treatment_id": null, "treatment_name": "TODO Treatment - DrugsIntervention group: Favipiravir (Zhejiang Hisun, China) plus Interferon beta-1a (CinnaGen, Iran). This group will receive 1600 mg Favipiravir twice a day for the first day and 600 mg twice a day for the following four days, plus five doses of 44 mcg Interferon beta-1a every other day. Other supportive and routine care will be the same in both groups.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "TODO Treatment - DrugsControl group: Lopinavir/Ritonavir (Heterd company, India) plus Interferon beta-1a (CinnaGen, Iran). This group will receive 200/50 mg Lopinavir/Ritonavir twice a day for the seven days, plus five doses of 44 mcg Interferon beta-1a every other day. Other supportive and routine care will be the same in both groups.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": 1513, "treatment_name": "Favipiravir+interferon beta 1a", "treatment_type": "Antivirals+interferons", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 1613, "treatment_name": "Interferon beta 1a+lopinavir+ritonavir", "treatment_type": "Interferons+antivirals", "pharmacological_treatment": "Pharmacological treatment"}]